SWANSON v. ELI LILLY AND COMPANY

District Court, S.D. Indiana·Decided November 15, 2024·No. 1:23-cv-00831·Unknown

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF INDIANA INDIANAPOLIS DIVISION

RACHAEL SWANSON, ) ) Plaintiff, ) ) v. ) Case No. 1:23-cv-00831-TWP-TAB ) LILLY USA, LLC, ) ) Defendant. ) ORDER ON DEFENDANT'S MOTION FOR SUMMARY JUDGMENT This matter is before the Court on Defendant Lilly USA, LLC's ("Lilly") Motion for Summary Judgment (Filing No. 71). Plaintiff Rachael Swanson ("Swanson") initiated this action alleging unlawful employment practices, after she was terminated from Lilly for refusing to receive the COVID-19 vaccine. Swanson asserts claims under the Americans with Disabilities Act of 1990 ("ADA"), Title VII of the Civil Rights Act of 1964 ("Title VII"), and the Age Discrimination in Employment Act ("ADEA") (Filing No. 1). For the following reasons, Lilly's Motion is granted. I. BACKGROUND The facts stated below are not necessarily objectively true, but as required by Federal Rule of Civil Procedure 56, they are presented in the light most favorable to Swanson as the non-moving party. See Zerante v. DeLuca, 555 F.3d 582, 584 (7th Cir. 2009); Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 255 (1986). A. The Parties Lilly is a pharmaceutical company headquartered in Indianapolis, Indiana. Swanson began working for Lilly in 1998 as a sales representative (Filing No. 73-3 at 4 [25:2-8]). In 2013, she became an Executive Sales Representative in Lilly's Diabetes Business Unit and served in that role until she was terminated on November 15, 2021. Id. at 5 [26:23-27:15]. Swanson's sales territory covered various cities in Florida and her main customers were endocrinologists. Id. In Swanson's role, she had to visit healthcare providers treating patients with diabetes to educate them on Lilly's diabetes-related medications. Id. at 21 [161:17-19]; Id. at 22 [169:16-19]. Swanson acted as the

face of Lilly and was responsible for building strong relationships with her customers. Id. at 23 [171:7-12]. B. COVID: The Global Pandemic1 "As the Seventh Circuit noted in a recent decision, 'COVID [] requires no introduction.'" Bar Indy LLC v. City of Indianapolis, 508 F. Supp. 3d 334, 338 (S.D. Ind. 2020). The Coronavirus disease ("COVID") is a very contagious disease that spread quickly throughout the United States and across the globe beginning in early 2020.2 The virus transmits rapidly from person to person, primarily through respiratory droplets emitted by coughing or sneezing that can travel multiple feet and remain in the air for several hours, and also through lingering particles on surfaces. Mays v. Dart, 974 F.3d 810, 814 (7th Cir. 2020). In March 2020, the White House announced a nationwide emergency and began instituting wide-scale travel bans and social distancing

measures, while states implemented shutdowns to prevent the spread of COVID.3

1 Federal Rule of Evidence 201 governs judicial notice of adjudicative facts. The Rule provides "The court may judicially notice a fact that is not subject to reasonable dispute because it: (1) is generally known within the trial court's territorial jurisdiction; or (2) can be accurately and readily determined from sources who cannot reasonably be questioned." Fed. R. Evid. 201(c).

2 About COVID-19, CDC.GOV, https://www.cdc.gov/covid/about/?CDC_AAref_Val=https://www.cdc.gov/coronavirus/2019-ncov/your- health/about-covid-19.html (last visited October 9, 2024).

3 CDC Museum COVID-19 Timeline, CDC.gov, https://www.cdc.gov/museum/timeline/covid19.html (last visited October 9, 2024). In February 2021, the first COVID vaccines were approved by the Food and Drug Administration.4 The vaccine was first made accessible to high-risk populations, but as months passed, the vaccine became more broadly available to individuals (Filing No. 73-2 at 9 [120:11- 121:4]. When vaccine availability increased, the federal government implemented COVID mandates for "federal employees and contractors" and "call[ed] on employers to do the same."5

C. COVID's Impact on Lilly Lilly and its employees were impacted by COVID. Between January and November of 2021, 688 employees reported to Lilly's Employee Health Services Team that they had tested positive for COVID-19 (see Filing No. 73-4). Some employees were hospitalized, and even worse died, from COVID (Filing No. 73-2 at 17 [226:20-227-8]). During this time, Lilly learned that President Joseph Biden intended to issue Executive Order ("E.O.") 14042, a COVID vaccine mandate for federal contractors (Filing No. 73-1 ¶ 4). Lilly understood that pursuant to E.O. 14042, any of its contracts with the United States government would be jeopardized if its employees were not vaccinated against COVID. Id. The forthcoming E.O. informed Lilly's decision to implement a vaccine policy. Id.

D. Lilly's COVID Vaccine Policy On August 12, 2021, Lilly announced that it would require COVID vaccinations for all U.S.-based employees, effective November 15, 2021, to help "protect the health and safety of Lilly employees." (Filing No. 73-8 at 3 [269:7-14]). Lilly explained that "as a science-based company, [they] thoroughly reviewed all the data and options available to [them]. And [they] believe[d] this decision [was] in the best interests of [their] employees, [their] families and the patients [they]

4 Id.

5 Fact Sheet: Biden Administration Announces Details of Two Major Vaccination Policies, WHITEHOUSE.GOV (Nov. 4, 2021), https://www.whitehouse.gov/briefing-room/statements-releases/2021/11/04/fact-sheet-biden- administration-announces-details-of-two-major-vaccination-policies/ (last visited May 10, 2024). serve." (Filing No. 73-7.) Lilly also announced that employees could submit medical and religious accommodation requests and detailed the steps by which to do so (Filing No. 73-6). 1. Lilly's Accommodation Process Following the Vaccine Policy announcement, Lilly informed employees that they could submit medical and religious accommodation requests and detailed the specific steps by which to

do so (Filing No. 73-7; Filing No. 73-9). Employees who planned to request medical or religious accommodations were required to complete and submit the accommodation forms by Friday, September 10, 2021 (Filing No. 73-6 at 3). The deadline was established to provide Lilly with enough time to fully consider medical or religious accommodation requests, as well as to provide those employees whose exemption requests were conditionally granted sufficient time to secure a non-customer-facing role and any employees whose exemption requests were denied sufficient time to become vaccinated, all by November 15, 2021 (Filing No. 73-10 at 8-9). a. Medical Accommodations Lilly's Workplace Accommodation Team (the "WPA Team"), which included medical professionals, was responsible for handling medical accommodation requests (Filing No. 73-8 at

5 [289:4-13]). The WPA Team relied on science-based evidence and guidance from the Centers for Disease Control and Prevention ("CDC") to create a defined set of guidelines and to evaluate each medical accommodation request on an individualized basis (Filing No. 73-10 at 9-11).

Free access — add to your briefcase to read the full text and ask questions with AI

SWANSON v. ELI LILLY AND COMPANY, (S.D. Ind. 2024).

SWANSON v. ELI LILLY AND COMPANY (SWANSON v. ELI LILLY AND COMPANY) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Sutton v. United Air Lines, Inc.
527 U.S. 471 (Supreme Court, 1999)
Kotwica v. Rose Packing Co., Inc.
637 F.3d 744 (Seventh Circuit, 2011)
Nelson v. Napolitano
657 F.3d 586 (Seventh Circuit, 2011)
Melvin D. Reed v. The Great Lakes Companies, Inc.
330 F.3d 931 (Seventh Circuit, 2003)
Willard L. Hemsworth, II v. quotesmith.com, Inc.
476 F.3d 487 (Seventh Circuit, 2007)
Zerante v. DeLuca
555 F.3d 582 (Seventh Circuit, 2009)
Gates v. Caterpillar, Inc.
513 F.3d 680 (Seventh Circuit, 2008)
Dorsey v. Morgan Stanley
507 F.3d 624 (Seventh Circuit, 2007)
Sink v. Knox County Hospital
900 F. Supp. 1065 (S.D. Indiana, 1995)
Sikiru Adeyeye v. Heartland Sweeteners, LLC
721 F.3d 444 (Seventh Circuit, 2013)